Logo
Chat on WhatsApp

CDSCO License for Photodiode subretinal prosthesis  system

Medical Device Information

Device Class
Class C

Intended Use

Designed to provide visual function to a patient with vision loss due to retinal degeneration by detecting light, converting it into electrical signals, and relaying them to the  retina for neural stimulation.

Manufacturing License
MD9
Import License
MD15
CDSCO License for Photodiode subretinal prosthesis  system

Comprehensive Guide to CDSCO Licensing for Photodiode Subretinal Prosthesis System

As specialists with over 25 years of experience in medical device regulatory compliance, we understand the nuanced requirements for bringing advanced neurological devices like the Photodiode Subretinal Prosthesis System to the Indian market. This device, classified as Class C under the CDSCO framework, is designed to restore some visual function by converting light into electrical signals to stimulate the retina — a cutting-edge solution for retinal degeneration.

Navigating the regulatory landscape for such innovative medical technologies demands precise knowledge of CDSCO processes, documentation, timelines, and costs. Below, we provide an expert, step-by-step guide to obtaining the necessary MD9 manufacturing license and import approvals, tailored specifically to this device type.


CDSCO Regulatory Framework for Photodiode Subretinal Prosthesis System

India's Central Drugs Standard Control Organization (CDSCO) governs the regulation of medical devices through a risk-based classification system. The Photodiode Subretinal Prosthesis System falls under Class C, indicating a moderate to high risk due to its neurological application and implantable nature.

Class C devices require licensing directly from the Central Licensing Authority, reflecting the stringent oversight necessary for patient safety and efficacy assurance. The regulatory journey involves multiple stages including test licensing, product testing, documentation, audits, and finally, license grant.

Risk Classification and License Requirements

  • Device Risk Class: C
  • Intended Use: Neural stimulation of retina to restore vision
  • Category: Neurological Devices
  • Applicable License: MD9 (Manufacturing License for Class C & D devices)
  • Notification Reference: 29/Misc/03/2020-DC (201), dated 27.09.2021

For detailed information on device classification, manufacturers can refer to this Medical Device Classification guide.

Manufacturing License Process (MD9)

The MD9 license process is comprehensive and involves several critical steps:

  1. Test License Application (Form MD13): Before full manufacturing approval, an applicant must secure a test license valid for 1-2 years. This allows initial product manufacturing for testing purposes.

  2. Product Testing: The device must be tested in CDSCO-approved labs to validate compliance with safety and performance requirements. See the list of CDSCO testing laboratories for authorized facilities.

  3. Document Preparation: Compile detailed documentation including Device Master File, Plant Master File, Risk Management File, and Quality Management System (QMS) evidence.

  4. License Application (Form MD7): Submit the application with supporting documents through the CDSCO MD Online Portal.

  5. Audit and Inspection: CDSCO inspectors conduct audits of facilities and review documents.

  6. Query Resolution: Address any queries or clarifications from the regulatory authorities promptly.

  7. License Grant (Form MD9): Upon successful compliance, the MD9 manufacturing license is issued.

For a detailed walkthrough, our MD9 License Guide offers practical insights.

Manufacturing License Documents Required

For the Photodiode Subretinal Prosthesis System, the following documents are essential:

  • Company Constitution and Incorporation Documents
  • Proof of Ownership or Lease of Manufacturing Premises
  • Technical Staff Qualification and Experience Certificates
  • No Objection Certificates (NOC) for Fire Safety and Pollution Control
  • Device Master File (DMF): Detailed design, specifications, and performance data. Our Device Master File guide covers key elements.
  • Plant Master File (PMF): Description of manufacturing facilities and processes (Plant Master File Guide)
  • Essential Principles Checklist: Compliance with Indian medical device standards
  • Risk Management File: Risk analysis and mitigation strategies, aligned with ISO 14971 (Risk Management guide)
  • Test Reports: From CDSCO-approved laboratories
  • Product Labels and Instructions for Use (IFU)
  • Quality Management System Documentation: Typically ISO 13485:2016 certified

Import License Process (MD15)

If you are an importer of the Photodiode Subretinal Prosthesis System, an MD15 license is mandatory:

  1. Document Preparation: Includes existing manufacturing license, Free Sale Certificate from country of origin, ISO 13485 certification, CE certificate, and relevant master files.

  2. Application Submission: Through the CDSCO MD Online portal using Form MD14.

  3. Review and Query Resolution: CDSCO evaluates application and raises queries if needed.

  4. License Issuance: Upon satisfaction, MD15 import license is granted.

Note, unlike manufacturing licenses, no test license is required for importers.

Our Import License Guide explains this process in detail.

Import License Documents Required

  • Valid Manufacturing License of the device from the country of origin
  • Free Sale Certificate
  • ISO 13485:2016 Certificate
  • CE Certificate (if applicable)
  • Device Master File and Plant Master File
  • Wholesale License (if applicable)
  • Company incorporation documents

Timeline and Processing Duration

Process StepApproximate Duration
Test License (MD13)1.5 to 2 months
Product Testing1 to 1.5 months
Document PreparationConcurrent with testing
MD9 License Application4 to 5 months total

Overall, manufacturers should anticipate a total timeframe of approximately 4 to 5 months from application submission to license grant, assuming timely responses to queries and audit scheduling.

Government Fees and Costs

  • MD9 License Application Fee: ₹50,000 per application
  • Product Fee: ₹1,000 per product

Additional costs include testing fees at approved laboratories and expenses related to audit preparation and QMS implementation.

Common Challenges and Solutions

Challenge 1: Complex Documentation Preparation

  • Solution: Utilize templates and expert consulting to ensure Device Master Files and Risk Management Files meet CDSCO expectations.

Challenge 2: Delays in Testing and Audit Scheduling

  • Solution: Engage with CDSCO-approved labs early and schedule audits promptly; maintain open communication with notified bodies.

Challenge 3: Query Resolution Delays

  • Solution: Assign a dedicated regulatory liaison to respond quickly and comprehensively to CDSCO queries.

Challenge 4: Compliance with Evolving Standards

  • Solution: Stay updated on CDSCO notifications and international standards; implement continuous training for technical staff.

Expert Consultation and Support

Having supported over 500 companies in successfully securing CDSCO licenses, we provide tailored regulatory consulting services including:

  • Gap analysis and readiness assessment
  • Documentation drafting and review
  • Coordination with testing laboratories and notified bodies
  • Application submission and follow-up
  • Training on CDSCO regulatory updates

Our proven approach helps manufacturers of neurological devices like the Photodiode Subretinal Prosthesis System navigate complex regulatory requirements efficiently.

Getting Started with Your CDSCO License Application

  1. Assess Your Device Classification: Confirm Class C status and understand the implications.

  2. Prepare Technical Documentation: Begin compiling your Device Master File, Risk Management File, and QMS documentation.

  3. Apply for Test License (MD13): Submit your test license application via the CDSCO MD Online Portal.

  4. Schedule Product Testing: Identify and coordinate with CDSCO-approved testing laboratories early.

  5. Engage a Notified Body: For audits, consult the list of notified bodies accredited for MD9 licensing.

  6. Prepare for Audit: Implement corrective actions and ensure manufacturing site readiness.

  7. Submit MD9 License Application: Complete and file Form MD7 with all supporting documents.

  8. Respond to Queries Promptly: Maintain proactive communication with CDSCO.

By following these steps and leveraging expert guidance, manufacturers and importers can streamline the regulatory approval process for the Photodiode Subretinal Prosthesis System and accelerate their entry into the Indian market.

For personalized assistance, contact our regulatory consulting team to discuss your project specifics and obtain a tailored compliance roadmap.

Get Expert Help

Free consultation for your medical device license

24/7 Support Available

Why Choose Us

500+ Licenses Obtained
100% Success Rate
15+ Years Experience
24/7 Support Available

About the Author

avatar
Tails Azimuth
@Twitter